Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan A Grupp

Showing results (51-60 of 238) with videos related to

Pageof 24
Sort By:
Pediatric Blood & Cancer|June 30, 2012
Feasibility of a tandem autologous peripheral blood stem cell transplant regimen for high risk neuroblastoma in a cooperative group setting: a Pediatric Oncology Group study: a report from the Children's Oncology GroupMeaghan Granger, Stephan A Grupp, Morris Kletzel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2020
Dissecting the Tumor-Immune Landscape in Chimeric Antigen Receptor T-cell Therapy: Key Challenges and Opportunities for a Systems Immunology ApproachGregory M Chen, Andrew Azzam, Yang-Yang Ding, et al.
Advances in Therapy|March 27, 2025
Impact of Different Definitions of Vaso-Occlusion on Efficacy Assessments in Sickle Cell Disease Clinical TrialsHaydar Frangoul, Franco Locatelli, Michael J Eckrich, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2003
Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signalingValerie I Brown, Junjie Fang, Keith Alcorn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2019
ReplyDaniel W Lee, Elena Mead, Bianca D Santomasso, et al.
Transplantation and Cellular Therapy|September 20, 2020
Analysis of Time to Complete Response after Defibrotide Initiation in Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell TransplantationPaul G Richardson, Angela R Smith, Nancy A Kernan, et al.
Cytotherapy|January 21, 2014
Relation of clinical culture method to T-cell memory status and efficacy in xenograft models of adoptive immunotherapyDavid M Barrett, Nathan Singh, Xiaojun Liu, et al.
Blood|July 29, 2009
Long-term protection from syngeneic acute lymphoblastic leukemia by CpG ODN-mediated stimulation of innate and adaptive immune responsesAlix E Seif, David M Barrett, Michael Milone, et al.
Transplantation and Cellular Therapy|July 12, 2024
Verification of the Prediction Accuracy of a Biomarker-Based Prognostic for Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) After Hematopoietic Cell Transplantation (HCT)Santosh Putta, Bradford Young, Polly Pine, et al.
Bone Marrow Transplantation|May 25, 2023
Prevention of veno-occlusive disease/sinusoidal obstruction syndrome: a never-ending story and no easy answerSelim Corbacioglu, Stephan A Grupp, Paul Gerard Richardson, et al.
Pageof 24

Showing results (51-60 of 238) with videos related to

Sort By:
Pageof 24
Pediatric Blood & Cancer|June 30, 2012
Feasibility of a tandem autologous peripheral blood stem cell transplant regimen for high risk neuroblastoma in a cooperative group setting: a Pediatric Oncology Group study: a report from the Children's Oncology GroupMeaghan Granger, Stephan A Grupp, Morris Kletzel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2020
Dissecting the Tumor-Immune Landscape in Chimeric Antigen Receptor T-cell Therapy: Key Challenges and Opportunities for a Systems Immunology ApproachGregory M Chen, Andrew Azzam, Yang-Yang Ding, et al.
Advances in Therapy|March 27, 2025
Impact of Different Definitions of Vaso-Occlusion on Efficacy Assessments in Sickle Cell Disease Clinical TrialsHaydar Frangoul, Franco Locatelli, Michael J Eckrich, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2003
Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signalingValerie I Brown, Junjie Fang, Keith Alcorn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2019
ReplyDaniel W Lee, Elena Mead, Bianca D Santomasso, et al.
Transplantation and Cellular Therapy|September 20, 2020
Analysis of Time to Complete Response after Defibrotide Initiation in Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell TransplantationPaul G Richardson, Angela R Smith, Nancy A Kernan, et al.
Cytotherapy|January 21, 2014
Relation of clinical culture method to T-cell memory status and efficacy in xenograft models of adoptive immunotherapyDavid M Barrett, Nathan Singh, Xiaojun Liu, et al.
Blood|July 29, 2009
Long-term protection from syngeneic acute lymphoblastic leukemia by CpG ODN-mediated stimulation of innate and adaptive immune responsesAlix E Seif, David M Barrett, Michael Milone, et al.
Transplantation and Cellular Therapy|July 12, 2024
Verification of the Prediction Accuracy of a Biomarker-Based Prognostic for Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) After Hematopoietic Cell Transplantation (HCT)Santosh Putta, Bradford Young, Polly Pine, et al.
Bone Marrow Transplantation|May 25, 2023
Prevention of veno-occlusive disease/sinusoidal obstruction syndrome: a never-ending story and no easy answerSelim Corbacioglu, Stephan A Grupp, Paul Gerard Richardson, et al.
Pageof 24